Compare MNKD & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNKD | DX |
|---|---|---|
| Founded | 1991 | 1987 |
| Country | United States | United States |
| Employees | N/A | 22 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.8B |
| IPO Year | 2004 | N/A |
| Metric | MNKD | DX |
|---|---|---|
| Price | $2.78 | $13.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $8.64 | ★ $14.25 |
| AVG Volume (30 Days) | ★ 6.6M | 5.1M |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 15.30% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $348,966,000.00 | N/A |
| Revenue This Year | $33.40 | N/A |
| Revenue Next Year | $16.48 | N/A |
| P/E Ratio | $140.75 | ★ $5.66 |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $2.52 | $10.79 |
| 52 Week High | $6.51 | $14.93 |
| Indicator | MNKD | DX |
|---|---|---|
| Relative Strength Index (RSI) | 23.75 | 27.32 |
| Support Level | N/A | $12.30 |
| Resistance Level | $6.08 | $13.72 |
| Average True Range (ATR) | 0.37 | 0.30 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 7.79 | 18.94 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.